erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
the report called this �one of the most significant perils to humans resulting from human activity.�
.
.
us/world
.
anr is a not for profit organisation that relies on sponsors and donations.
.